G2-checkpoint abrogation in irradiated lymphocytes: A new cytogenetic approach to assess individual radiosensitivity and predisposition to cancer.

Terzoudi, Georgia I; Hatzi, Vasiliki I; Barszczewska, Katarzyna; Manola, Kalliopi N; Stavropoulou, Chryssa; Angelakis, Philip; Pantelias, Gabriel E

Terzoudi, Georgia I; Hatzi, Vasiliki I; Barszczewska, Katarzyna; Manola, Kalliopi N; Stavropoulou, Chryssa; Angelakis, Philip; Pantelias, Gabriel E.

Affiliation

Terzoudi GI; Radiobiology and Cytogenetics, IR-RP, National Center for Scientific Research (NCSR) Demokritos, Athens, Greece. gterzoudi@rrp.demokritos.gr

Int J Oncol ; 35(5): 1223-30, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19787278

Subject(s)

G2 Phase/radiation effects; Genetic Predisposition to Disease; Genetic Techniques; Lymphocytes/radiation effects; Neoplasms/genetics; Radiation Tolerance/genetics; DNA Damage/radiation effects; G2 Phase/genetics; Hematologic Tests; Humans; Reproducibility of Results

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Radiation Tolerance / Lymphocytes / G2 Phase / Genetic Techniques / Genetic Predisposition to Disease / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Oncol Journal subject: NEOPLASIAS Year: 2009 Document type: Article Affiliation country: Greece Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links